Neuroleptic malignant syndrome induced by metoclopramide.
Neuroleptic malignant syndrome (NMS) associated with metoclopramide is rare. NMS probably results from neuroleptic-induced dopamine receptor blockade. We describe a case and have found only seven reports of metoclopramide-induced NMS in the literature.
Donnet
A
A
Clinique de Neurologie, CHU Timone, Marseille, France.
Harle
J R
JR
Dumont
J C
JC
Alif Cherif
A
A
D000368:Aged; D006801:Humans; D008297:Male; D008787:Metoclopramide / Q000009:adverse effects*; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology* / Q000503:physiopathology
D008787:Metoclopramide